This message contains images. If you don't see images, click here to view.
Advertise in this news brief.


Text version   RSS   Subscribe   Unsubscribe   Archive   Media Kit March 19, 2014    SLAS2015    Moving? New job? Let SLAS know.    





Providing clean, uninterrupted electrical power.

Certified UPS’s to protect your laboratory’s critical instrumentation and resolve current and potential power issues.


Manufacturing for Chemists since 1928

Laboratory & Custom Reagents ISO 17025 Accredited Certificate #3336.01 Custom Packaging Configurations Order Today 800-858-9682

An Online Scientific Wiki

A collaborative compilation of the world's laboratory technology knowledge grown and updated by an online community.




What Do You Think About Open Access Publishing?
SLAS    Share    Share on FacebookTwitterShare on LinkedinE-mail article
SLAS is interested in your experience and opinions regarding open access publishing of scientific journals.

Please take 5-7 minutes (really, that's all!) before March 28 to complete the multiple choice 2014 SLAS Open Access Publishing Survey, and you could win a full registration to SLAS2015 (Feb. 7-11, 2015, in Washington, DC) or an Amazon gift card.

If you are a JALA SAGEtrack or JBS SAGEtrack user, please access this survey by using the link that was sent to you via e-mail.


SLAS ELN Reports: Researchers Advance Protein-Protein Interactions as Small Molecule Drug Targets
SLAS    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Innovators James A. Wells of University of California, San Francisco, Haian Fu of Emory University and Mary Ellen Digan of Novartis are presenters in the Spring 2014 SLAS Webinar Series, Protein-Protein Interactions as Small Molecule Drug Targets.

In this SLAS Electronic Laboratory Neighborhood e-zine article, the three share accomplishments of, and stories behind, their work in this growing area of research.

Wells presented March 18, and his webinar will be available on demand shortly; Fu and Digan will present live April 15 and May 13, respectively.

Sponsored Content

JBS Special Issue Call for Papers: Therapeutic Antibody Discovery and Development
SLAS    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Guest Editors Rob Howes and Joseph G. McGivern are looking for manuscript proposals related to all aspects of the discovery and development of therapeutic antibodies with an emphasis on biochemical, cell-based and analytical assays. Submit abstracts by April 25 for consideration. Invited authors will be notified by May 1 and final manuscripts will be due Aug. 1. More


It's Time to Submit SLAS2015 Presentation Abstracts
SLAS    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Abstracts are now being accepted for the 4th Annual SLAS Conference and Exhibition, Feb. 7-11, Washington, DC.

Podium abstracts are due July 28; later deadlines are in place for poster abstracts.

The SLAS2015 scientific program features seven educational tracks: Assay Development and Screening; Automation and High-Throughput Technologies; Bioanalytical Techniques; Biomarker Discovery and Application; Drug Discovery Strategies; Informatics; and Micro/Nano Technologies.

JBS April Issue Now Online for Members and Subscribers
SLAS    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Andrew J. deMello and his team from the Institute for Chemical Bioengineering at ETH Zurich and Chungbuk National University published the review article, Droplet-Based Microfluidics: Enabling Impact on Drug Discovery, in this issue.

The team touches on pertinent studies in microfluidic platforms, droplet generation, droplet library creation, probing droplet contents, assays (ligand-binding, PCR-based, proteomics) and chip operations (cell-free protein synthesis, 3D cell culture, organisms), while acknowledging much work remains to be done to bring experimental approaches to market.

Nexar® HTP, Inline Liquid Handler

Inline liquid handling system for sample and reagent processing in 384-well Array Tape™. Flexible inline modular options include dispensing, plate storage, incubation and dehydration. Check it out!
Microfluidics and Miniaturization Made Easy

Microfabrication and Design Services for Custom and OEM Devices. Let our 40+ years’ experience in photomask fabrication work for you.
To learn more click here

Donald E. Ingber: Aha Moment Defines Career
SLAS    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The SLAS2015 keynote speaker from Harvard University describes himself as a visual person, who loves art, form and pattern.

Learn of Ingber's aha moment when he tied the shape of a tensegrity sculpture by Kenneth Snelson shown in an undergraduate sculpture class to the work he was doing in the laboratory to culture cells.

"That was the starting point for the rest of my life in science," Ingber states in the Discovery Channel Curiosity series video clip, How Do Art and Architecture Influence Biology. "I felt I had seen something that no one ever had seen."

8 Detection Modes - 1 Microplate Reader
SpectraMax® i3 Multi-Mode Detection Platform is a flexible plate reader that evolves to fit your application needs. This system offers one-of-a kind ScanLater™ Western Blot Detection, SpectraMax® MiniMax™ Imaging Cytometer, as well as built in absorbance, fluorescence, and luminescence detection modes while the patented cartridge design allows FP, HTRF, and AlphaScreen® field upgrades – all on a single detection platform. View video and learn more
Multiplexed Capture of Secreted Proteins for Screening
New in 2014! MultiCyt™ QBeads enable multiplexed assays for secreted proteins, including cytokines and growth factors, at the pace and price of screening. Choose up to 30 analytes, assemble with a no-wash protocol, and read a 384-well plate in < 15 minutes using IntelliCyt's iQue™ Screener. Learn More
Saf-T-Pak 6.2 Compliance Training, Now Offering CEUs
6.2 Shipping Training is required biennially – when was the last time you trained? All training is conducted in accordance with the regulations published by IATA, ICAO, US DOT, Transport Canada, RID/ADR and the Universal Postal Union


Building New Drugs Just Got Easier
Science Daily    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Scientists at The Scripps Research Institute have developed a method for modifying organic molecules that significantly expands the possibilities for developing new pharmaceuticals and improving old ones. "This is a technology that can be applied directly to many medicinally relevant compounds," said Jin-Quan Yu, a professor in TSRI's Department of Chemistry and the senior author of the new report, which appears in Nature. More

Europe Faces Up to Big Pharma Over Clinical Data
New Scientist    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Next week could see a major step forward in the battle to pass laws compelling drug companies to release all the data from their clinical drugs trials. On March 12, the European Parliament is expected to finalize and give formal approval to much amended draft legislation, with a full vote taking place at the beginning of April. But even as members deliberate, pharmaceutical companies will be fighting back. More


'Acid Bath' Stem Cell Developments Rapidly Accumulate
Bioscience Technology    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Amid plagiarism claims, the Riken Institute's Haruko Obokata reportedly told a Waseda University professor she plans to withdraw her 2011 thesis, a Waseda spokesperson told Bioscience Technology. Why this matters: days earlier, a global press conference delivered the news that four of 14 co-authors on two controversial Obokata "acid bath" papers — along with the coauthors' boss — wanted the papers retracted mid-investigation. More

China Bans Genetic Testing
Genetic Engineering & Biotechnology News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
For nearly a half-century, interrupted only by the Cultural Revolution, China promoted the growth of genetic testing to prevent and address birth defects through state-run hospitals, as well as charities and increasingly in recent years, private enterprises. Then last month, China reversed course. The China Food and Drug Administration posted a new regulation that immediately banned genetic testing — even for previously approved services. More

Predict toxicity earlier!

Eliminate cardiotoxic compounds and identify potential cardiac drug candidates earlier in the
                                  drug discovery process.
Multispan: Your Drug Discovery Partner

Let Multispan be your one-stop shop partner from cell line and assay development to screening, lead optimization and profiling - reduce your cycle time to IND. More>> Email:

A Link Between Blood and Plasma Trace Metals in Alzheimer's Disease?
By Dr. Afsaneh Motamed-Khorasani    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Alzheimer's disease, or AD, is the most common type of dementia in the elderly, with a rapidly increasing prevalence. In the past three decades, we have witnessed remarkable advances in our understanding of AD, both in terms of the disease course and its symptoms. About 20 genes have been identified to be associated with an altered risk for late onset AD, which could potentially serve as new therapeutic candidates. However, the risk variability and limited power of allelic risk candidates have led to the conclusion that there must be other factors, such as toxic exposure and environmental factors. More

Fighting Antibiotic Resistance With 'Molecular Drill Bits'    Share    Share on FacebookTwitterShare on LinkedinE-mail article
In response to drug-resistant "superbugs" that send millions of people to hospitals around the world, scientists are building tiny, "molecular drill bits" that kill bacteria by bursting through their protective cell walls. They presented some of the latest developments on these drill bits, better known to scientists as antimicrobial peptides, at the 247th National Meeting & Exposition of the American Chemical Society. More

Reports Make Progress In Transforming C-H Bonds Into Druglike Motifs
Chemical & Engineering News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Carbon-hydrogen bonds are ubiquitous, and chemists would love to transform them at will into entry points to materials or drugs. Despite great strides, that goal is far from a reality. A pair of reports now furthers the C–H bond transformation field by taking advantage of weak coordination to palladium catalysts. The chemistry comes from Jin-Quan Yu and coworkers at Scripps Research Institute, La Jolla, Calif. More

Big Data Tackles Tiny Molecular Machines
Lab Manager    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Open, feed, cut. Such is the humdrum life of a motor molecule, the subject of new research at Rice University, that eats and excretes damaged proteins and turns them into harmless peptides for disposal. The why is obvious: Without these trash bins, the Escherichia coli bacteria they serve would die. And thanks to Rice, the how is becoming clearer. More

Direction Control of Oriented Self-Assembly for 1D, 2D, and 3D Microarrays of Anisotropic Rectangular Nanoblocks
Journal of the American Chemical Society    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Micrometric linear chains (1D arrays), monolayers (2D arrays), and superstructures (3D arrays) of anisotropic Mn3O4 nanocuboids were selectively produced by oriented self-assembly through evaporation of a dispersion. The 1D arrays were basically formed on a substrate via oriented self-assembly of the rectangular crystals in the 100 direction. The 2D and 3D microarrays were obtained by adjusting the particle concentration of the dispersion. More

Good things come
in small packages.
Ranging in size from 3/4” to 1.5” in diameter, the Valcor Scientific family of Instrument Class Solenoid Valves are available in direct acting two-way normally closed / normally open, and universal three-way operating modes. Made with all PTFE, PEEK, PPS, or PCTFE wetted parts, body configurations include threaded ports, surface mount, and inline and gradient manifolds. Compact size, low internal volumes, and low power consumption set our offering apart from the rest of the industry.
Cartiotox testing - the next generation
The CardioExcyte 96 is a novel system supporting extracellular field potential recordings and non-invasive impedance-based measurements from beating networks or clusters of cardiomyocytes. Together with the Patchliner, the CardioExcyte 96 takes your safety screening to a new level. Learn more at booth #429 at the ToxExpo meeting!
Cloud Solutions Designed with Scientists in Mind
  • Save time and money with
       Acquire™ lab supplies
       management software.
  • Streamline compound
       management with Store™
  • Make internal and external
       compounds and assays
       accessible to all project
       teams with Request™
  • Visualize™ enables
       securely sharing compound
       and biological assay results.

  • Career

    Research Analyst – Scientific Data Management
    IDA/Science & Technology Policy Institute
    US – Washington, D.C.

    R&D Engineer 4
    Los Alamos National Laboratory
    US – NM – Los Alamos

    Sr. Automation Systems Engineer
    BioSoft Integrators
    US – CA – San Diego

    More jobs at SLAS Career Connections


    SLAS Point-to-Point
    Colby Horton, Vice President of Publishing, 469.420.2601
    Download media kit

    Dennis Hall, Senior Content Editor, 469.420.2656   
    Contribute news

    This edition of SLAS Point-to-Point was sent to ##Email##. To unsubscribe from receiving SLAS Point-to-Point, click here. To unsubscribe from all SLAS e-mail communications, please click here. Did someone forward this edition to you? Subscribe here — it's free!

    SLAS Terms of Use Policy
    Recent issues

    March 12, 2014
    March 5, 2014
    Feb. 26, 2014
    Feb. 19, 2014

    7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063